Moderna (MRNA) had the highest return on January 2 and this year by a large-cap US stock or large-cap US stock, returning 12.6%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 12.64% |
BioNTech SE (BNTX) | 6.82% |
Viatris (VTRS) | 5.56% |
Las Vegas Sands (LVS) | 4.95% |
Incyte (INCY) | 4.9% |
Wynn Resorts (WYNN) | 4.15% |
Biogen (BIIB) | 3.94% |
Merck (MRK) | 3.74% |
Kinsale Capital (KNSL) | 3.71% |
Tapestry (TPR) | 3.69% |
Campbell Soup Company Common Stock (CPB) | 3.64% |
Cheniere Energy Partners (CQP) | 3.64% |
EnergySolutions (ES) | 3.63% |
Dominion Energy (D) | 3.59% |
Tyson Foods (TSN) | 3.58% |
Regeneron Pharmaceuticals (REGN) | 3.56% |
Amgen (AMGN) | 3.52% |
Hershey (HSY) | 3.5% |
Pilgrims Pride (PPC) | 3.5% |
United Therapeutics (UTHR) | 3.47% |
Citigroup (C) | 3.39% |
Kellanova (K) | 3.35% |
ConAgra Foods (CAG) | 3.29% |
AbbVie (ABBV) | 3.18% |
Avangrid (AGR) | 3.09% |
Large-cap stocks are treated as having a market cap of $10B+.
